“ Adherence and Or Discontinuation of Imatinib Mesylate in Patients With Chronic Myeloid Leukemia ”. Brazilian Journal of Pharmaceutical Sciences 52, no. 4 (dezembro 1, 2016): 581–589. Acessado maio 19, 2024. https://www.revistas.usp.br/bjps/article/view/128373.